Filing Details
- Accession Number:
- 0001127602-25-003559
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-07 16:09:51
- Reporting Period:
- 2025-02-06
- Filing Date:
- 2025-02-07
- Accepted Time:
- 2025-02-07 16:09:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263739 | G Inge Thulin | Merck &Amp; Co., Inc. 126 East Lincoln Avenue Rahway NJ 07065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-06 | 2,833 | $88.25 | 2,933 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
